Iontophoresis Patch With Battery

Manufacturer of self-contained iontophoresis platforms featuring an integrated micro-power architecture. Engineered for ambulatory workflow efficiency. Designed for use with clinician-prescribed ionic solutions to provide a sustained delivery window.

Ambulatory Workflow Efficiency for Transdermal Platforms.

Standard iontophoresis setups require desktop controllers, tying up clinical space and limiting patient mobility. The TOP-RANK Self-Contained Iontophoresis System transitions this process into a fully wearable drug delivery platform.

By embedding an integrated micro-power architecture directly into the patch assembly, we provide an untethered solution for clinicians and device-brand partners. Once loaded with the prescribed ionic solution and applied to the patient, the self-contained system initiates a sustained microcurrent delivery. This allows the patient to leave the facility immediately, optimizing ambulatory workflow efficiency while maintaining the targeted dosing framework.

Manufacturing a drug-device combination platform requires the seamless integration of flexible electronics, stable chemical matrices, and power management.

1. Micro-Power Architecture & Output Control

• The Design: The platform incorporates a low-voltage DC micro-power source connected to the conductive elements.
• The Function: Upon fluid activation, the system provides a stable current output under defined load, eliminating the need for external capital equipment or lead wires.

2. Microcurrent Control & Density Management (mA/cm²)

• The Engineering: Instead of rapid, high-intensity delivery, the integrated system provides an approximately 0.1 mA constant output.
• The Result: Distributing the target dosage over an extended contact duration drastically lowers the localized current density (mA/cm²). This engineering outcome naturally reduces the risk of localized current sensation without altering the prescribed mA-min protocol.

3. Automated Depletion Protocol

• System Logic: The integrated circuit requires no manual intervention. The micro-battery is precisely calibrated and designed to cease current output upon battery depletion, corresponding to the completion of the target dosage framework.

The integrated power sources are calibrated to align with commonly used iontophoresis dosing frameworks.

(Note: Run times are approximate. The system is designed to accommodate patient-to-patient skin impedance variability and solution conductivity differences.)

Manufacturing Maturity for Drug-Device Partnerships.

Producing a reliable, self-contained wearable platform requires strict design controls and component validation. As an MDSAP and ISO 13485 certified manufacturer, TOP-RANK engages in deep engineering collaboration with device-brand partnerships and pharmaceutical developers.

Our co-development capabilities include:

• Storage Stability Validation: Rigorous accelerated aging tests to validate battery shelf-life and prevent power degradation during transit and warehousing.
• Impedance Tolerance: Tuning the internal circuitry and Ag/AgCl matrix to accommodate patient-to-patient skin impedance variability.
• Platform Customization: Modifying the reservoir capacity or form factor to align with specific molecular delivery requirements.

Initiate an Engineering Discussion

Assess the manufacturability and system integration of your transdermal concept. Contact our RA/QA and engineering teams for a technical dossier and feasibility assessment of our self-contained platforms.

Request Feasibility Assessment & Technical Dossier

Hot Tags: iontophoresis patch with battery, China iontophoresis patch with battery manufacturers, suppliers, factory, iomed patch, dexamethasone for iontophoresis patch, iontophoresis cortisone patch, Iontophoresis Pad, Iontophoresis Patches, ionto pads